Study Finds New Heath Risks from Prempro

Our firm represents a number of women who have sued Wyeth Pharmaceuticals after being diagnosed with breast cancer which we believe was caused by use of the medicine Prempro.  In a study released today, The American Medical Association has revealed that a study of the drug Prempro causes an increased cancer risk in women who take it.  This result took the leaders of the study by surprise.  In an article in Medicalnewstoday.com, the lead investigator of the study stated, "This latest study reinforces the original finding that combined hormone therapy of estrogen plus progestin should not be taken for the purpose of reducing disease in post-menopausal women," Chlebowski said. "These findings also reinforce the need for monitoring for cancer in women who have taken the combination of estrogen plus progestin."  This is strong support for the thousands of women who developed breast cancer after taking Prempro in an effort to avoid bone loss or for cardiovascular benefits.  This study demonstrates that any potential benefit of disease prevention is outweighed by Prempro's potential to cause breast cancer.  The full study can be found here.